Trial Outcomes & Findings for Effects of Exercise Intervention on Aging-related Motor Decline (NCT NCT01787292)

NCT ID: NCT01787292

Last Updated: 2020-02-20

Results Overview

Estimate of Volume of oxygen consumption (VO2peak) using YMCA protocol for cardiovascular assessment.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

33 participants

Primary outcome timeframe

Baseline, 12 weeks, 24 weeks

Results posted on

2020-02-20

Participant Flow

Community-dwelling individuals were recruited for participation using approved flyer and advertising materials. All participants gave voluntary written consent prior to participation. After consenting, participants were randomly assigned to one of two 12-week exercise interventions involving a followed by cross-over to the other intervention.

Participant milestones

Participant milestones
Measure
Experimental: Aerobic Exercise, Then Balance Training
Participants completed a 12-week interval aerobic cycling under supervised trainers three times per week for 20-45 minutes per session. After two to four week washout period, participants entered a second 12-week intervention involving light stretching and balance exercise under a supervised trainer three times per week for 20-45 minutes per session.
Experimental: Balance Training, Then Aerobic Exercise
Participants completed a 12-week light stretching and balance exercise program under a supervised trainer three times per week for 20-45 minutes per session.Participants completed an interval aerobic cycling under supervised trainer three times per week for 20-45 minutes per session. After two to four week washout period, participants completed a 12-week interval aerobic cycling under supervised trainers three times per week for 20-45 minutes per session.
Crossover Exercise Interventions
STARTED
17
16
Crossover Exercise Interventions
COMPLETED
15
14
Crossover Exercise Interventions
NOT COMPLETED
2
2
Home Based Exercise Program
STARTED
15
14
Home Based Exercise Program
COMPLETED
12
13
Home Based Exercise Program
NOT COMPLETED
3
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Experimental: Aerobic Exercise, Then Balance Training
Participants completed a 12-week interval aerobic cycling under supervised trainers three times per week for 20-45 minutes per session. After two to four week washout period, participants entered a second 12-week intervention involving light stretching and balance exercise under a supervised trainer three times per week for 20-45 minutes per session.
Experimental: Balance Training, Then Aerobic Exercise
Participants completed a 12-week light stretching and balance exercise program under a supervised trainer three times per week for 20-45 minutes per session.Participants completed an interval aerobic cycling under supervised trainer three times per week for 20-45 minutes per session. After two to four week washout period, participants completed a 12-week interval aerobic cycling under supervised trainers three times per week for 20-45 minutes per session.
Crossover Exercise Interventions
Withdrawal by Subject
2
2
Home Based Exercise Program
Withdrawal by Subject
3
1

Baseline Characteristics

Effects of Exercise Intervention on Aging-related Motor Decline

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Exercise Interventions for Crossover Design
n=33 Participants
This study was a cross-over design with two groups to which participants were randomized. Group one received a 12-week Aerobic exercise intervention and then crossed over into a balance exercise intervention. Group two received the balance intervention for 12 weeks and then crossed over into the aerobic exercise intervention. All completing participants then engaged in a home based exercise program during which they were instructed to exercise thrice weekly over 24 weeks.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
n=5 Participants
Age, Categorical
>=65 years
25 Participants
n=5 Participants
Age, Continuous
69.05 years
STANDARD_DEVIATION 5.98 • n=5 Participants
Sex: Female, Male
Female
19 Participants
n=5 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
16 Participants
n=5 Participants
Race (NIH/OMB)
White
17 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Cardiovascular Efficiency
25.25 ml/kg(min)
STANDARD_DEVIATION 9.74 • n=5 Participants
Ipsilateral Silent Period
22.39 milliseconds
STANDARD_DEVIATION 4.73 • n=5 Participants
FMRI of Right Motor Cortex
1.85 area under curve
STANDARD_DEVIATION 1.2 • n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 12 weeks, 24 weeks

Population: Estimated VO2 peak values in ml/kg(min)

Estimate of Volume of oxygen consumption (VO2peak) using YMCA protocol for cardiovascular assessment.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=15 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Estimate Cardiovascular Efficiency After Aerobic Exercise
Baseline
24.01 ml/kg(min)
Standard Deviation 9.29
Estimate Cardiovascular Efficiency After Aerobic Exercise
12-Week post
31.2 ml/kg(min)
Standard Deviation 8.6
Estimate Cardiovascular Efficiency After Aerobic Exercise
24-week post-cross
32.3 ml/kg(min)
Standard Deviation 6.8

PRIMARY outcome

Timeframe: Baseline, 12 weeks, 24 weeks

Population: Sedentary older adults who engaged in less than 45 minutes of regular exercise per week

Estimated VO2peak using YMCA cycle test completed over nine to twelve minutes.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=14 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Estimate of Cardiovascular Efficiency After Balance Training
Pre
22.83 ml/kg(min)
Standard Deviation 7.35
Estimate of Cardiovascular Efficiency After Balance Training
12-Weeks
24.72 ml/kg(min)
Standard Deviation 9.36
Estimate of Cardiovascular Efficiency After Balance Training
24-week post-cross
23.58 ml/kg(min)
Standard Deviation 8.25

PRIMARY outcome

Timeframe: Baseline, 12 weeks, 24 weeks

Duration of ipsilateral silent period from Transcranial magnetic stimulation measured in milliseconds

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=15 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Silent Period Duration After Exercise Cycling Program
Baseline
22 milliseconds
Standard Deviation 7.8
Silent Period Duration After Exercise Cycling Program
12-Week post
26.2 milliseconds
Standard Deviation 7.5
Silent Period Duration After Exercise Cycling Program
24-week post-cross
27.5 milliseconds
Standard Deviation 7.4

PRIMARY outcome

Timeframe: Baseline, 12 weeks, 24 weeks

Population: Sedentary older adults engaging in less than 45 minutes of total activity per week

Ipsilateral silent period duration as assessed by TMS

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=14 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Silent Period Duration for Balance Group
Pre
23 milliseconds
Standard Deviation 8.9
Silent Period Duration for Balance Group
12-Weeks
21.2 milliseconds
Standard Deviation 5.1
Silent Period Duration for Balance Group
24-week post-cross
26.2 milliseconds
Standard Deviation 8.1

PRIMARY outcome

Timeframe: Baseline to 24 Weeks with cross-over

Population: Analysis of area under curve of right primary motor cortical area

Participants who exercise will evidence larger increases in interhemispheric inhibition as assessed by functional magnetic resonance measured by a z-normalized area under curve of right primary motor cortex. The area under the curve is an estimate of the fMRI hemodynamic response impulse response function. A higher number of AUC indicates less interhemispheric inhibition. In contrast, a lower number in this analysis indicates higher interhemispheric inhibition.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=15 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
fMRI Interhemispheric Inhibition Improvement After Aerobic Exercise
Pre
1.5 Z-transformed impulse response function
Standard Deviation 1.2
fMRI Interhemispheric Inhibition Improvement After Aerobic Exercise
12 week intervention
.58 Z-transformed impulse response function
Standard Deviation .98
fMRI Interhemispheric Inhibition Improvement After Aerobic Exercise
24 week post-crossover
.58 Z-transformed impulse response function
Standard Deviation .98

PRIMARY outcome

Timeframe: Baseline, 12 weeks, 24 weeks

Area under the curve of fMRI measures of right motor cortex BOLD profile will remain similar to pre measurements. The BOLD profile is the z-normalized area under the curve value of the fMRI impulse response function. A higher number indicates less interhemispheric inhibition.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=14 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
fMRI Interhemispheric Inhibition Improvement After Balance Training
Pre
1.49 Z-transformed impulse response function
Standard Deviation .88
fMRI Interhemispheric Inhibition Improvement After Balance Training
12-Weeks
.62 Z-transformed impulse response function
Standard Deviation .52
fMRI Interhemispheric Inhibition Improvement After Balance Training
24-week post-cross
.62 Z-transformed impulse response function
Standard Deviation .52

PRIMARY outcome

Timeframe: 24 and 48 weeks

Comparison of home based aerobic exercise intervention to assessments made after completion of crossover intervention in Participants receiving aerobic condition first. VO2peak estimation completed using the YMCA protocol investigating overall volume of oxygen consumption as a function of heart rate during work loads. Estimated VO2 peak values are in ml/kg(min).

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=12 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Comparison of Cardiovascular Efficiency for Aerobic Exercise First Group After Home-based Intervention
Within one week of completing 24 week intervention
25.25 ml/kg(min)
Standard Deviation 12.25
Comparison of Cardiovascular Efficiency for Aerobic Exercise First Group After Home-based Intervention
Within one week of completing 48 Week Intervention
21.2 ml/kg(min)
Standard Deviation 9.88

PRIMARY outcome

Timeframe: 24 and 48 weeks

Population: Participants completed both exercise interventions but completed Balance training prior to engaging in aerobic exercise training.

VO2peak estimation completed using the YMCA protocol investigating overall volume of oxygen consumption as a function of heart rate during work loads.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=12 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Comparison of Cardiovascular Efficiency for Balance Exercise First Group After Home-based Intervention
Within one week of completing 24 week intervention
25.5 ml/kg(min)
Standard Deviation 12.8
Comparison of Cardiovascular Efficiency for Balance Exercise First Group After Home-based Intervention
Within one week of completing 48 Week Intervention
20.8 ml/kg(min)
Standard Deviation 12.2

PRIMARY outcome

Timeframe: Baseline, 12 weeks, 24 weeks

Comparison of silent period duration at 24 weeks compared to baseline

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=15 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Comparison of Silent Period Duration After Aerobic Exercise
Pre
20.58 milliseconds
Standard Deviation 7.5
Comparison of Silent Period Duration After Aerobic Exercise
12-Weeks
26.2 milliseconds
Standard Deviation 7.5
Comparison of Silent Period Duration After Aerobic Exercise
24-week post-cross
27.5 milliseconds
Standard Deviation 7.4

PRIMARY outcome

Timeframe: 24 and 48 weeks

Population: Participants completing balance training then crossing over into aerobic exercise were then tested for effects of facility based treatments against home exercise.

Comparison of Home based training effects on TMS measures of silent period duration as compared to facility based exercise programs.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=12 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Comparison of Silent Period Duration After Balance Exercise
Within one week of completing 24 week intervention
26.54 milliseconds
Standard Deviation 8.4
Comparison of Silent Period Duration After Balance Exercise
Within one week of completing 48 Week Intervention
21.6 milliseconds
Standard Deviation 9.3

SECONDARY outcome

Timeframe: 24 and 48 weeks

Heart rate in aerobic target zone is measured in percentage of time in at least 50% of participants heart rate reserve.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=14 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Target Heart Rate Zone for Balance First Participants
Within one week of completing 24 week intervention
58.4 percentage of time
Standard Deviation 34.6
Target Heart Rate Zone for Balance First Participants
Within one week of completing 48 Week Intervention
88.5 percentage of time
Standard Deviation 14.7

SECONDARY outcome

Timeframe: 24 and 48 weeks

Targeted Heart Rate Zone among participants compared among short term exercise groups

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=15 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Target Heart Rate Zone After Aerobic Exercise First
Within one week of completing 24 week intervention
93.7 percentage of time
Standard Deviation 10.1
Target Heart Rate Zone After Aerobic Exercise First
Within one week of completing 48 Week Intervention
70.6 percentage of time
Standard Deviation 22.5

SECONDARY outcome

Timeframe: 24 and 48 weeks

Population: Participants completing home based interventions compared to facility based interventions - measured in time in aerobic zone.

Measured heart rate after home based intervention Technical implementation at the facility level prevented acquisition of these metrics until late in the project.

Outcome measures

Outcome measures
Measure
Experimental: Aerobic First
n=7 Participants
Aerobic Exercise: Interval based spin exercise under a supervised trainer three times per week for 20-45 minutes per session.
Heart Rate Workload After Home Based Intervention
Within one week of completing 24 week intervention
78 percentage of time
Standard Deviation 18
Heart Rate Workload After Home Based Intervention
Within one week of completing 48 Week Intervention
48 percentage of time
Standard Deviation 30

Adverse Events

Experimental Intervention: Aerobic Exercise First

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental Intervention: Balance Exercise First

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Keith McGregor

Health Science Specialist

Phone: 4043216111

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place